
Passport for Care: a Useful Resource for the Delivery of Care to Childhood Cancer Survivors

Passport for Care: a Useful Resource for the Delivery of Care to Childhood Cancer Survivors is organized by Baylor College of Medicine (BCM).
Release Date: 04/01/2022
Expiry Date: 03/31/2024
Description:
Needs Statement:
Over 80% of childhood cancer patients become survivors of childhood cancer. However, survivors may be at risk for long-term late effects of their treatments with chemotherapy, radiation, surgery, and other modalities. Over time, therapy has been modified to reduce the late effects by using more intensified approaches for those at greatest risk and lessening therapeutic applications where that can be done. However, even survivors treated over the last two decades are at risk may be at risk for serious or life-threatening late effects. While excellent, comprehensive guidelines have been developed by the NIH-supported Children’s Oncology Group, their application can be challenging to implement in the clinic particularly when clinicians may not have access to a survivorship care plan for the survivor listing the history of treatment exposures. The Passport For Care (PFC) is a clinical decision support tool, that is freely available to clinicians and to survivors themselves and makes available a survivorship care plan and guideline-based recommendations tailored to the survivor’s history of treatment exposure. This module introduces the PFC to clinicians, its benefits, and how it may be used to guide follow-up screening for late effects of cancer treatment
Objectives:
At the conclusion of the conference, participants should be able to:
• Discuss the frequency of and source of risks facing long-term survivors of childhood cancer.
• Describe the role for survivorship care plans in screening for late effects of cancer treatments.
• Articulate how a clinical decision support tool can support delivering care in alignment with national guidelines.
Additional details will be posted as soon as information is available.